Bacane, Rowel Y.
HRN: 21-74-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/03/2022
08/10/2022
IV
500mg
Q8
Asa Appendicitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes